Hikma Pharmaceuticals

Visit the Hikma Pharmaceuticals website

Hikma Pharmaceuticals is a fast growing pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products. Hikma's operations are conducted through three businesses: Branded, Injectables and Generics, based primarily in the Middle East and North Africa region, where it is a market leader, the United States and Europe. In 2015, Hikma achieved revenues of $1.44 billion and profit attributable to shareholders of $252 million.